- Home
- MCRB vs AGAE Comparison
MCRB vs AGAE Comparison
Compare MCRB & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- AGAE
- Stock Information
- Founded
- MCRB 2010
- AGAE 2017
- Country
- MCRB United States
- AGAE United States
- Employees
- MCRB N/A
- AGAE N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- AGAE Cable & Other Pay Television Services
- Sector
- MCRB Health Care
- AGAE Telecommunications
- Exchange
- MCRB Nasdaq
- AGAE Nasdaq
- Market Cap
- MCRB 72.0M
- AGAE 84.7M
- IPO Year
- MCRB 2015
- AGAE N/A
- Fundamental
- Price
- MCRB $7.05
- AGAE $3.01
- Analyst Decision
- MCRB Hold
- AGAE
- Analyst Count
- MCRB 5
- AGAE 0
- Target Price
- MCRB $73.67
- AGAE N/A
- AVG Volume (30 Days)
- MCRB 93.5K
- AGAE 646.6K
- Earning Date
- MCRB 05-07-2025
- AGAE 06-13-2025
- Dividend Yield
- MCRB N/A
- AGAE N/A
- EPS Growth
- MCRB N/A
- AGAE N/A
- EPS
- MCRB 8.98
- AGAE N/A
- Revenue
- MCRB N/A
- AGAE $9,256,023.00
- Revenue This Year
- MCRB N/A
- AGAE N/A
- Revenue Next Year
- MCRB N/A
- AGAE N/A
- P/E Ratio
- MCRB $0.84
- AGAE N/A
- Revenue Growth
- MCRB N/A
- AGAE 36.15
- 52 Week Low
- MCRB $6.53
- AGAE $0.66
- 52 Week High
- MCRB $30.60
- AGAE $3.79
- Technical
- Relative Strength Index (RSI)
- MCRB 38.95
- AGAE 70.08
- Support Level
- MCRB $7.32
- AGAE $1.77
- Resistance Level
- MCRB $7.86
- AGAE $3.79
- Average True Range (ATR)
- MCRB 0.63
- AGAE 0.48
- MACD
- MCRB 0.10
- AGAE 0.12
- Stochastic Oscillator
- MCRB 28.89
- AGAE 66.67
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.